Arizona State Retirement System Trims Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Arizona State Retirement System trimmed its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 23,937 shares of the company’s stock after selling 399 shares during the quarter. Arizona State Retirement System’s holdings in HealthEquity were worth $1,587,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. Comerica Bank grew its position in shares of HealthEquity by 82,280.3% during the 3rd quarter. Comerica Bank now owns 58,490 shares of the company’s stock valued at $4,273,000 after purchasing an additional 58,419 shares in the last quarter. Natixis Advisors L.P. increased its stake in HealthEquity by 7.2% in the 3rd quarter. Natixis Advisors L.P. now owns 17,664 shares of the company’s stock worth $1,290,000 after acquiring an additional 1,180 shares during the last quarter. Gotham Asset Management LLC bought a new position in HealthEquity in the 3rd quarter worth about $1,103,000. Loomis Sayles & Co. L P raised its holdings in shares of HealthEquity by 57.8% in the 3rd quarter. Loomis Sayles & Co. L P now owns 399,683 shares of the company’s stock valued at $29,197,000 after acquiring an additional 146,372 shares in the last quarter. Finally, American Century Companies Inc. boosted its position in shares of HealthEquity by 23.1% during the 3rd quarter. American Century Companies Inc. now owns 900,408 shares of the company’s stock valued at $65,775,000 after acquiring an additional 168,979 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Barclays upped their price objective on shares of HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a research report on Friday, February 23rd. Barrington Research restated an “outperform” rating and set a $100.00 price objective on shares of HealthEquity in a research report on Friday, March 22nd. Bank of America upped their target price on shares of HealthEquity from $93.00 to $97.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. JPMorgan Chase & Co. raised their price target on HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a research report on Tuesday, April 2nd. Finally, Royal Bank of Canada upped their price objective on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, March 20th. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $96.17.

HealthEquity Price Performance

HQY opened at $79.85 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76. The stock’s 50 day simple moving average is $80.84 and its 200 day simple moving average is $74.05. The firm has a market cap of $6.85 billion, a price-to-earnings ratio of 124.77, a PEG ratio of 1.32 and a beta of 0.53. HealthEquity, Inc. has a 1 year low of $48.86 and a 1 year high of $84.49.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. The firm had revenue of $262.39 million during the quarter, compared to analyst estimates of $258.56 million. As a group, analysts predict that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 2,558 shares of the company’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $82.59, for a total transaction of $211,265.22. Following the completion of the transaction, the executive vice president now directly owns 47,438 shares of the company’s stock, valued at $3,917,904.42. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, EVP Delano Ladd sold 2,558 shares of HealthEquity stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the sale, the executive vice president now directly owns 47,438 shares in the company, valued at approximately $3,917,904.42. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total value of $2,576,925.00. Following the transaction, the director now owns 32,123 shares of the company’s stock, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. Insiders have sold a total of 71,322 shares of company stock valued at $5,682,895 in the last quarter. Insiders own 2.70% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.